No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

GALEN regimen, Phase 2 trial

byKathleen Lau

December 31, 2021

in StudyGraphics

Reading Time: 1 min read

RELATED REPORTS

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

Tags: #cancer advanced follicular lymphoma advanced lymphoma blood blood cancer cancer chemo-free chemotherapy complete response rate CRR efficacy outcomes febrile neutropenia FL follicular lymphoma GALEN hematology high tumor burden high tumour burden induction infection infusion-related reaction IWG 1999 Criteria lenalidomide maintenance neutropenia Obinutuzumab oncology os overall survival pfs previously untreated lymphoma progression-free survival skin reaction survival outcomes untreated lymphoma

Moderate caffeine intake may not be associated with cardiometabolic pregnancy complications

RelatedReports

Development of a risk index for colorectal cancer screening

Chronic Disease

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

May 12, 2026

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

April 30, 2026

Thoracic radiotherapy improves survival in small-cell lung cancer patients

Chronic Disease

Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

April 15, 2026

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization

Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026

Influenza vaccine not associated with increased risk of epilepsy in children

Immune dysfunction is associated with a higher risk of breakthrough COVID-19 infection

2 Minute Medicine Rewind January 3, 2022

Kangaroo mother care linked to better neonatal outcomes

Mediterranean diet and mindfulness-strategies reduced risk of low-birth-weight newborns

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result